Given the enormous enrichment of the UPR in NSD3-amplified tumors (Figure 1E) and the tight junction between UPR signaling and anti-tumor immunity [35,36], we sought to determine whether the UPR is associated with the suppressive immunological features of NSD3-amplified LUSC. This evidence concerns the gene NSD3 and neoplasm.